
Neuronetics Income Statement 2025-2011 | STIM
Brief overview of financial results at Neuronetics
The overview follows changes across a five-year period. Neuronetics reported revenue of $49.2 million in 2020 and $149 million by 2025. The cumulative result was +202.9%, corresponding to roughly 24.8% per year. The company expanded its revenue base at a high speed.
At the gross-profit level, the result moved from 37.7 million dollars to 72.3 million dollars, a change of +91.8%. Direct costs outpaced revenue, limiting the benefit of changes in sales. At the margin level, the figure shifted from 76.5% to 48.5%. A lower margin indicates deterioration in the economics of the core business.
The operating result measured by EBITDA moved from −21.4 million dollars to −28 million dollars, or −30.9%. Operating performance weakened relative to revenue. EBITDA margin was −43.4% at the start and −18.8% at the end. Higher profitability strengthens the quality of operating growth.
The net financial result changed from −27.5 million dollars to −39 million dollars. The loss widened and increased the financial risk.
The five-year change in capitalization reached −72.3%: from $293 million to $81.1 million. Market expectations deteriorated over the period.
Conclusion
The financial trajectory is weak and requires a cautious interpretation. Key strengths include higher operating efficiency and revenue expansion. The most visible risks are declining net profitability, a narrow EBITDA buffer and pressure from direct costs. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement Neuronetics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
81.1 M | 39 M | 35.2 M | 121 M | 85.1 M | 293 M | 71.3 M | 151 M | - | - | - | - | - | - | - |
Shares |
66 M | 31.7 M | 28.7 M | 26.9 M | 25.5 M | 18.8 M | 18.4 M | 8.95 M | - | - | - | - | - | - | - |
Historical Prices |
1.23 | 1.23 | 1.23 | 4.51 | 3.34 | 15.5 | 2.9 | 17.4 | - | - | - | - | - | - | - |
Net Income |
-39 M | -43.7 M | -30.2 M | -37.2 M | -31.2 M | -27.5 M | -29 M | -24.1 M | -16.1 M | -11.2 M | - | - | - | - | - |
Revenue |
149 M | 74.9 M | 71.3 M | 65.2 M | 55.3 M | 49.2 M | 62.7 M | 52.8 M | 40.4 M | 34.2 M | - | - | - | - | - |
Cost of Revenue |
76.8 M | 20.6 M | 18.5 M | 15.5 M | 11.7 M | 11.6 M | 15.4 M | 12.4 M | 9.63 M | 6.62 M | - | - | - | - | - |
Gross Profit |
72.3 M | 54.2 M | 51.7 M | 49.7 M | 43.7 M | 37.7 M | 47.3 M | 40.3 M | 30.8 M | 27.6 M | - | - | - | - | - |
Operating Income |
-31.4 M | -34.6 M | -30.6 M | -35.1 M | -27.6 M | -22.3 M | -26.9 M | -19.8 M | -13.6 M | -9.34 M | - | - | - | - | - |
Interest Expense |
716 K | 7.29 M | 5.42 M | 4.25 M | 4.02 M | 4.52 M | 3.68 M | 3.69 M | 2.81 M | 1.84 M | - | - | - | - | - |
EBITDA |
-28 M | -32.5 M | -28.5 M | -33.5 M | -26.5 M | -21.4 M | -25.9 M | -19 M | -13 M | -8.66 M | - | - | - | - | - |
Operating Expenses |
104 M | 88.7 M | 82.3 M | 84.8 M | 71.2 M | 60 M | 74.2 M | 60.2 M | 44.4 M | 36.9 M | - | - | - | - | - |
General and Administrative Expenses |
31.5 M | 297 K | 417 K | 25.5 M | 25.6 M | 18.2 M | 17.5 M | 13.7 M | 8.57 M | 6.93 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Neuronetics
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
66.2 M | 69.6 M | 69 M | 67.3 M | 66.2 M | 61.5 M | 55.7 M | 30.3 M | 30.1 M | 29.5 M | 29.1 M | 28.9 M | 28.6 M | 28 M | 27.3 M | 27 M | 26.8 M | 26.6 M | 26.4 M | 26.3 M | 25.9 M | 25.2 M | 19 M | 18.9 M | 18.7 M | 18.7 M | 18.6 M | 18.5 M | 18.4 M | 18 M | 17.7 M | 17.4 M | 245 K | 226 K | 211 K | 194 K | 173 K | 167 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-12.7 M | -10.8 M | - | -9.04 M | -10.1 M | -12.7 M | - | -13.3 M | -9.83 M | -7.87 M | - | -9.39 M | -4.9 M | -10.5 M | - | -7.61 M | -10.4 M | -10.8 M | - | -8.15 M | -7.52 M | -7.88 M | -3.66 M | -3.42 M | -7.76 M | -12.6 M | -7.55 M | -6.87 M | -7.09 M | -7.53 M | -6.14 M | -4.96 M | -7.5 M | -5.5 M | -4.92 M | -3.75 M | -2.87 M | -4.51 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
38.1 M | 34.5 M | - | 37.3 M | 38.1 M | 32 M | - | 18.5 M | 16.4 M | 17.4 M | - | 17.9 M | 17.6 M | 15.5 M | - | 16.5 M | 16.3 M | 14.2 M | - | 13.8 M | 14.2 M | 12.3 M | 15.6 M | 12.4 M | 9.74 M | 11.5 M | 17.4 M | 16 M | 16.6 M | 12.7 M | 15.6 M | 13.7 M | 13.3 M | 10.2 M | 12.1 M | 10.5 M | 10.3 M | 7.53 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
20.4 M | 18.3 M | - | 20.2 M | 20.4 M | 16.2 M | - | 4.53 M | 4.27 M | 4.33 M | - | 6.12 M | 4.84 M | 4.14 M | - | 3.57 M | 4.04 M | 3.48 M | - | 3.14 M | 2.75 M | 2.22 M | 3.76 M | 2.66 M | 2.32 M | 2.81 M | 4.22 M | 4.19 M | 4.17 M | 2.81 M | 3.71 M | 3.03 M | 3.24 M | 2.46 M | 2.96 M | 2.64 M | 2.5 M | 1.54 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
17.8 M | 16.2 M | - | 17.1 M | 17.8 M | 15.7 M | - | 14 M | 12.2 M | 13.1 M | - | 11.8 M | 12.8 M | 11.4 M | - | 12.9 M | 12.3 M | 10.7 M | - | 10.7 M | 11.5 M | 10.1 M | 11.8 M | 9.79 M | 7.42 M | 8.66 M | 13.1 M | 11.8 M | 12.4 M | 9.92 M | 11.9 M | 10.7 M | 10 M | 7.7 M | 9.15 M | 7.86 M | 7.81 M | 5.99 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-8.06 M | -9 M | - | -7.32 M | -8.06 M | -11 M | - | -7.73 M | -8.51 M | -6.86 M | - | -8.87 M | -7.35 M | -9.91 M | - | -7.45 M | -9.8 M | -10.1 M | - | -7.18 M | -6.56 M | -6.91 M | -2.66 M | -2.42 M | -6.86 M | -10.4 M | -6.94 M | -6.33 M | -6.61 M | -7.06 M | -5.66 M | -4.33 M | -5.24 M | -4.6 M | -4.23 M | -2.81 M | -2.58 M | -3.99 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
188 K | 2.27 M | - | 2.21 M | 1.97 M | 1.92 M | - | 1.72 M | 1.98 M | 1.83 M | - | 1.18 M | 1.14 M | 1.25 M | - | 1.06 M | 1 M | 978 K | - | 993 K | 977 K | 985 K | 1.01 M | 1 M | 986 K | 1.52 M | 905 K | 930 K | 931 K | 919 K | 939 K | 928 K | 900 K | 921 K | 740 K | 807 K | 711 K | 550 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-7.66 M | -8.25 M | - | -6.82 M | -7.56 M | -10.1 M | - | -7.23 M | -7.91 M | -6.3 M | - | -8.37 M | -6.85 M | -9.39 M | - | -7.05 M | -9.5 M | -9.82 M | - | -6.41 M | -6.26 M | -6.63 M | -2.66 M | -1.68 M | -6.32 M | -10.1 M | -6.94 M | -5.56 M | -6.15 M | -6.85 M | -5.66 M | -3.66 M | -4.77 M | -4.47 M | -4.23 M | -2.36 M | -2.27 M | -3.99 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
25.8 M | 25.1 M | - | 24.4 M | 25.8 M | 26.8 M | - | 21.7 M | 20.7 M | 19.9 M | - | 20.6 M | 20.1 M | 21.3 M | - | 20.4 M | 22.1 M | 20.8 M | - | 17.8 M | 18 M | 17 M | 14.5 M | 12.2 M | 14.3 M | 19 M | 20.1 M | 18.1 M | 19 M | 17 M | 17.6 M | 15 M | 15.2 M | 12.3 M | 13.4 M | 10.7 M | 10.4 M | 9.98 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
12.2 M | 8.48 M | - | 11.1 M | 12.2 M | 8.46 M | - | 7.44 M | 6.15 M | 5.96 M | - | 6.34 M | 6.2 M | 6.61 M | - | 6.39 M | 6.36 M | 6.38 M | - | 6.44 M | 6.68 M | 6.1 M | 4.73 M | 4.21 M | 4.01 M | 5.29 M | 4.31 M | 4.28 M | 4.26 M | 4.6 M | 4.72 M | 3.24 M | 3.08 M | 2.64 M | 2.84 M | 2.26 M | 1.84 M | 1.64 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Neuronetics (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.